Reversible deafness related to long-term daily Azithromycin treatment in a child with cystic fibrosis. Dowle H, Unger S, Khalid S, Brown C, et al. Pediatr Pulmonol 2024;59:2990-2992.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dowle H, Unger S, Khalid S, Brown C, et al. Reversible deafness related to long-term daily Azithromycin treatment in a child with cystic fibrosis. Pediatr Pulmonol 2024;59:2990-2992.
PMID: 38860588